首页> 外文期刊>Biochemical Genetics >Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in Saudi newborns with stroke.
【24h】

Molecular characterization of factor V leiden G1691A and prothrombin G20210A mutations in Saudi newborns with stroke.

机译:沙特阿拉伯卒中新生儿中V因子leiden G1691A和凝血酶原G20210A突变的分子表征。

获取原文
获取原文并翻译 | 示例
           

摘要

This study examined a possible association between the mutations related to Factor V Leiden and Factor II (prothrombin) and stroke in Saudi neonates. A multiplex PCR was established to detect Factor V Leiden G1691A and prothrombin G20210A mutations in 72 neonatal stroke subjects and 70 healthy adult controls with no family history of thromboembolic diseases. The frequency of the homozygous normal genotype (GG) of both genes was found to be significantly lower in the stroke subjects than in the controls (P < 0.0001). The stroke cases also had higher frequencies of the combined Factor II heterozygous mutant form (GA) and the homozygous normal Factor V (GG) (P < 0.0001) and of the combined heterozygous Factor V and the homozygous normal Factor II genotypes (GG) (P = 0.0) than controls. The study concluded that prothrombin and Factor V Leiden may be important risk factors for neonatal stroke in Saudi children.
机译:这项研究检查了沙特新生儿中与因子V Leiden和因子II(凝血酶原)相关的突变与中风之间的可能关联。建立了多重PCR,以检测72例新生儿卒中患者和70例无血栓栓塞性疾病家族史的健康成人对照中的V因子Leiden G1691A和凝血酶原G20210A突变。发现中风受试者中两个基因的纯合正常基因型(GG)的频率显着低于对照组(P <0.0001)。中风病例的因子II杂合突变体形式(GA)和纯合子正常因子V(GG)的组合频率也较高(P <0.0001),杂合因子V和纯合因子II基因型(GG)的杂合子频率较高( P = 0.0)。研究得出结论,凝血酶原和凝血因子V Leiden可能是沙特儿童新生儿中风的重要危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号